Adherence Rate of Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Estimating the Adherence Rate of a Monthly Bubble Package Among Patients Prescribed Adjuvant Endocrine Therapy in Breast Cancer Survivors

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01694225

Enrollment

Registered

2012-09-27

Start date

2012-07-31

Completion date

2018-01-28

Last updated

2018-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

Breast cancer, Anti-estrogen therapy

Brief summary

This study aims to establish the feasibility of using a monthly bubble package to improve compliance rates among women prescribed adjuvant endocrine therapy.

Detailed description

This study uses Bubble packaging to provide a cost effective way to improve compliance and help direct further interventions to ensure adherence in women on anti-estrogen therapy for breast cancer.

Interventions

OTHERbubble packaging for monthly prescription

Monthly bubble packaging among women prescribed anti-estrogens

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

SUPPORTIVE_CARE

Masking

NONE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* 18 years of age or older * Estrogen receptor positive (\> 1% estrogen expression) by immunohistochemistry * Invasive breast cancer (stage I, II, III) or DCIS considered for adjuvant endocrine therapy

Exclusion criteria

* Patients with metastatic disease (stage IV) * Patients less than 18 years of age * Prisoners * Patients are unable to fill prescriptions at the BCC pharmacy due to insurance limitations or personal preference

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026